Shippenberg T S, Millan M J, Mucha R F, Herz A
Department of Neuropharmacology, Max-Planck Institut for Psychiatry, Planegg-Martinsried, F.R.G.
Eur J Pharmacol. 1988 Sep 13;154(2):135-44. doi: 10.1016/0014-2999(88)90090-8.
The role of beta-endorphin and mu-opioid receptors in mediating the motivational effect of lithium was examined by use of an unbiased place-preference conditioning procedure. Administration of lithium to drug-naive rats resulted in a dose-related aversion for the drug-associated place. Radiofrequency lesions of the medio-basal arcuate hypothalamus, which markedly reduced the levels of immunoreactive beta-endorphin in the hypothalamus, abolished the lithium-induced aversion. However, suppression of circulating beta-endorphin levels by chronic dexamethasone treatment was without effect. Infusion of the opioid antagonist, naloxone, throughout the conditioning procedure at a dose (0.5 mg/kg per h) that blocks mu- but not kappa-opioid receptors, resulted in the complete abolition of the lithium-induced place aversion. These data demonstrate an involvement of endogenous opioidergic systems in the motivational effect of lithium and indicate that the aversive properties of this drug result from its interactions with beta-endorphin and mu-opioid receptors in the CNS.
通过使用无偏倚的位置偏好条件反射程序,研究了β-内啡肽和μ-阿片受体在介导锂的动机效应中的作用。对未接触过药物的大鼠给予锂,导致对与药物相关位置的剂量相关厌恶。中基底弓状下丘脑的射频损伤显著降低了下丘脑免疫反应性β-内啡肽的水平,消除了锂诱导的厌恶。然而,慢性地塞米松治疗抑制循环β-内啡肽水平没有效果。在整个条件反射过程中以阻断μ-但不阻断κ-阿片受体的剂量(每小时0.5mg/kg)输注阿片拮抗剂纳洛酮,导致锂诱导的位置厌恶完全消除。这些数据表明内源性阿片能系统参与了锂的动机效应,并表明该药物的厌恶特性是由于其与中枢神经系统中的β-内啡肽和μ-阿片受体相互作用所致。